Mometasone furoate Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Drugs acting on the nose | Ear, Nose and Oropharynx
Items (12m)
123
Total Quantity
123
NHS Cost
£973
vs National Avg
-69.4%
MAPLE ACCESS PARTNERSHIP LLP prescribed 123 items of Mometasone furoate over the last 12 months at a cost of £973 to the NHS. This is 69.4% below the national average prescribing rate. Mometasone furoate is classified under Drugs acting on the nose in the BNF.
Monthly Prescribing Trend
Jun 2026
13
Jun 2026
12
Jun 2026
14
Jun 2026
12
Jun 2026
10
Jun 2026
9
Jun 2026
10
Jun 2026
3
Jun 2026
14
Jun 2026
9
Jun 2026
8
Jun 2026
9
Prescribing Details
| Total Items | 123 |
|---|---|
| Total Quantity | 123 |
| Total NHS Cost | £973 |
| Presentations | 1 different forms |
| vs National Average | -69.4% |
Mometasone furoate Prescribing Comparison
| This practice | 123 items |
|---|---|
| National average per practice | 402 items |
| Difference | -69.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.